Neglected aspects of false positive findings of mammography in breast cancer screening: Analysis of false positive cases from the Stockholm trial

British Medical Journal

Volumn 312, Issue 7026, 1996, Pages 273-276

  Lidbrink, E ^a   Elfving, J ^b   Frisell, J ^a   Jonsson, E ^c  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b Swedish Council on Technology Assessment in Health Care   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; SWEDEN;

EID: 0029671344     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7026.273     Document Type: Article

References (33)

1. Socialstyrelsen. Allmänna råd från Socialstyrelsen. Mammografiscreening 1986; 3:1-32.
2. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
3. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen year effect of screening on breast cancer mortality. Journal of the National Cancer Institute 1982;62:349-55.
4. Tabàr L, Fagerberg G, Gad A, Baldetorp L, Holmberg L, Gröntoft D, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;i:829-32.
5. Wright CJ. Breast cancer screening: a different look at the evidence. Surgery 1986;100:594-7.
6. Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA 1988;259:1512-9.
7. Devin JE. False alarms of breast cancer. Lancet 1989;ii:1257-8.
8. Andersson I, Janzon L, Pettersson H. Radiographic patterns of the mammary parenchyma. Variation with age at examination and age at first birth. Radiology 1981;138:59-62.
9. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer 1990;62:1018-22.
10. Lerman CE, Rimer BK. Psychosocial impact of cancer screening. Oncology 1993;7:67-72.
11. Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 1992;34:1129-34.
12. Skrabanek P. The cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care 1991;7:633-5.
13. Brown ML. Economic considerations in breast cancer screening of older women. J Gerontol 1992;47:51-8.
14. Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care 1991;7:604-15.
15. Mushlin AI, Fintor L. Is screening for breast cancer cost-effective? Cancer 1992;69:1957-62.
16. Okubo I, Glick H, Frumkin H, Eisenberg JM. Cost-effectivness analysis of mass screening for breast cancer in Japan. Cancer 1991;67:2021-9.
17. Miller AB. The cost and benefits of breast cancer screening. Am J Prev Med 1993;9:175-80.
18. Erichsen GG. Mammographical screening for cancer mammae - a cost-benefit analysis. Nord Med 1990;105:64-6.
19. Brown ML. Sensitivity analysis in the cost-effectiveness of breast cancer screening. Cancer 1992;69:1963-7.
20. van der Maas PJ, de Konig HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe JT, et al. The cost-effectiveness of breast cancer screening. Int J Cancer 1989;43:1055-60.
21. de Koning HJ, Van Ineveld BM, Van Oortmarssen GJ, De Haes JCJM, Colette HJA, Hendriks JHCL, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991;49:531-7.
22. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215:1777-85.
23. Tabar L, Gad A. Screening for breast cancer: the Swedish trial. Radiology 1981;138:219-22.
24. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.
25. Frisell J, Eklund G, Hellstrom L, Glas U, Somell A. The Stockholm breast cancer screening trial - 5-year results and stage at discovery. Breast Cancer Res Treat 1989;13:79-87.
26. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Design, first rounds results, and comparisons. Breast Cancer Res Treat 1986;8:45-54.
27. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
28. McLelland R, Pisano ED. The politics of mammography. Radiol Clin North Am 1992;30:235-41.
29. Fentiman IS. Pensive women, painful vigils: consequences of delay in assessment of mammographic abnormalities. Lancet 1988;i:1041-2.
30. Kopans DB, Swann CA. Observations on mammographic screening and false-positive mammograms. AJR Am J Roentgenol 1987;150:785-6.
31. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist L-E, Somell A. Randomized study of mammographic screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
32. Nielsen M, Jensen J, Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy. Cancer 1984;43:107-14.
33. Lidbrink E, Tornberg S, Azavedo E, Frisell J, Hjalmar M-L, Leifland K, et al. The general mammography screening program in Stockholm. Organisation and first results. Acta Oncol 1994;33:353-8.